Analiza ofert polskich touroperatorów na sezon 2012/2013 na podstawie turystyki wyjazdowej do Tunezji – jednego z najpopularniejszych kierunków wakacy / The analysis of polish tour operators’ offers for the season 2012/2013 on the basis of an outbound tourism to Tunisia − one of the most popular holida

Autor: Staszek, Monika, Brzezińska-Wójcik, Teresa, Świeca, Andrzej

Publikováno v: Prace Naukowe Uniwersytetu Ekonomicznego we Wrocławiu / Research Papers of Wrocław University of Economics. (304):314-324

Externí odkaz: https://www.ceeol.com/search/article-detail?id=179302

Concatenated CNN-Based Pneumonia Detection Using a Fuzzy-Enhanced Dataset

Autor: Abror Shavkatovich Buriboev, Dilnoz Muhamediyeva, Holida Primova, Djamshid Sultanov, Komil Tashev, Heung Seok Jeon

Publikováno v: Sensors, Vol 24, Iss 20, p 6750 (2024)

Pneumonia is a form of acute respiratory infection affecting the lungs. Symptoms of viral and bacterial pneumonia are similar. Rapid diagnosis of the disease is difficult, since polymerase chain reaction-based methods, which have the greatest reliabi

Externí odkaz: https://doaj.org/article/e454f54cb0a44428a8c6a4e19da2e5e9

Long-term safety and efficacy of pegunigalsidase alfa: A multicenter 6-year study in adult patients with Fabry disease

Autor: Hughes, Derralynn ^{1, ∗}, Gonzalez, Derlis ², Maegawa, Gustavo ³, Bernat, John A. ⁴, Holida, Myrl ⁴, Giraldo, Pilar ⁵, Atta, Mohamed G. ⁶, Chertkoff, Raul ⁷, Alon, Sari ⁷, Almon, Einat Brill ⁷, Rocco, Rossana ⁸, Goker-Alpan, Ozlem ⁹

Publikováno v: In Genetics in Medicine December 2023 25(12)

A phase III, open-label clinical trial evaluating pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease previously treated with other enzyme replacement therapies.

Autor: Holida M; Division of Medical Genetics and Genomics, Stead Family Department of Pediatrics, University of Iowa, Iowa City, Iowa, USA., Linhart A; Charles University, General University Hospital, Prague, Czech Republic., Pisani A; Department of Public Health, University Federico II of Naples, Naples, Italy., Longo N; Pediatrics Medical Genetics, University of Utah, Salt Lake City, Utah, USA., Eyskens F; Antwerp University Hospital UZA, Edegem, Belgium., Goker-Alpan O; Lysosomal and Rare Disorders Research and Treatment Center, Fairfax, Virginia, USA., Wallace E; University of Alabama at Birmingham, Birmingham, Alabama, USA., Deegan P; Lysosomal Disorders Unit, Cambridge University Hospitals NHS Foundation Trust and University of Cambridge, Cambridge, UK., Tøndel C; University of Bergen and Haukeland University Hospital, Bergen, Norway., Feldt-Rasmussen U; Department of Endocrinology and Metabolism, Rigshospitalet and Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark., Hughes D; LSDU, Royal Free London NHS Foundation Trust, and University College London, London, UK., Sakov A; DataSights Ltd, Haifa, Israel., Rocco R; Chiesi Farmaceutici S.p.A, Parma, Italy., Almon EB; Department of Product Development, Protalix Biotherapeutics, Carmiel, Israel., Alon S; Department of Product Development, Protalix Biotherapeutics, Carmiel, Israel., Chertkoff R; Department of Product Development, Protalix Biotherapeutics, Carmiel, Israel., Warnock DG; University of Alabama at Birmingham, Birmingham, Alabama, USA., Waldek S; University of Sunderland, Sunderland, UK., Wilcox WR; Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA., Bernat JA; Division of Medical Genetics and Genomics, Stead Family Department of Pediatrics, University of Iowa, Iowa City, Iowa, USA.

Publikováno v: Journal of inherited metabolic disease [J Inherit Metab Dis] 2025 Jan; Vol. 48 (1), pp. e12795. Date of Electronic Publication: 2024 Oct 09.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.